1Gregory J, Randall T, Anthony J, et al. PROACT: phase Ⅱ randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke [J]. Stroke, 1999, 29 (1): 4-11.
2Toshihiro U, Saburo S, Yoshiaki K, et al. Muhivafiable analysis of predictive factors related to outcome at 6 months after intraarterial thrombolysis for acute ischemic stroke [ J ]. Stroke, 1999, 30 (11): 2360-2365.
3Lewandowski CA, Frankel M, Tomsick TA, et al. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: emergency management of stroke (EMS) bridging trial [J]. Stroke, 1999, 30 (12): 2598-2605.
4Lisboa RC, Jovanovic BD. Alberts MJ. Analysis of the safety and efficacy of intra-arterial thrombolytic therapy in ischemic stroke [J]. Stroke, 2002, 33 (12): 2866-2871.
5Gregory JZ, Randall TH, Anthony JF, et al. Pproc, aphase Ⅱ ramdomized rrial of recombinant pro-Urokinade by direct arterial delivery in acute middle eerebeal artery stroke [J]. Stroke, 1998, 29 (1): 4.
6Bendszus M, Urbach H, Ries F, et al. Outcome after localintra - arterial fibrinolysis compared with the natural course of patients with a dense middle cerebral artery on early CT [J]. Neuroradiol, 1998, 40 (1): 54.
9Wardlaw J M, Warlaw CP. Thromholysis in acute ischemia stroke Does it work [J]. Stroke, 1992, 23 (9): 1826 - 1839.
10Arnold, M, Schroth G, Nedeltchev K, et al. Intra-arterial thrombolysis in 100 patients with acute stroke due to middle cerebral artery occlusion [J]. Stroke, 2002, 33 (9): 1828- 1833.
2Endo S, Kuwayama N, Hirashima Y, et al. Results of urgent thrombolysis in patients with major stroke and atherothrombotic occlusion of the cervical intemnal carotid artery. AJNR, 1998, 19(6):1169.
3Schumacher M, Yin L, Klisch A, et al. Local intra-arterial fibrinolysis without arterial occlusion? Neuroradiology, 1999, 41(7):530.
4Gomez CR, Misra VK, Morgan M, et al. Elective stenting of symptomatic middle cerebral artery stenosis. AJNR, 2000, 21(5):971.
4Shaltoni HM, Albright KC, Gonzales NR, et al. Is intra-arterialthrombolysis safe after full-dose intravenous recombinant tissue plas-minogen activator for acute ischemic stroke?. Stroke, 2007 ,38( 1):80-84.
5del Zoppo GJ, Higashida RT, Furlan AJ, et al. PROACT: a phaseII randomized trial of recombinant pro-urokinase by direct arterialdelivery in acute middle cerebral artery stroke. PROACT Investiga-tors. Prolyse in Acute Cerebral Thromboembolism. Stroke, 1998 ,29(1):4-11.
6Sekoranja L, Loulidi J, Yilmaz H, et al. Intravenous versus com-bined (intravenous and intra-arterial) thrombolysis in acute ische-mic stroke: a transcranial color-coded duplex sonography—guidedpilot study. Stroke, 2006,37 (7) : 1805-1809.
7Lisboa RC,Jovanovic BD,Alberts MJ. Analysis of the safety andefficacy of intra-arterial thrombolytic therapy in ischemic stroke.Stroke, 2002,33(12):2866-2871.
8Wahlgren N, Ahmed N, Ddvalos A, et al. Thrombolys- is with aheplase for acute isehaemic stroke in the Safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST) : an observational study[J]. Lancet, 2007, 369(9558): 275 282.
9Hacke W, Donnan G, Fieschi C, et al . Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials [J]. Lancet, 2004, 363(9411): 768-774.
10Tissue plasm inogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group[J]. N Engl J Med, 1995, 333(24): 1581-1587.
